Non-cardiogenic mechanisms for the pulmonary edema induced by scorpion venomDESHPANDE, Shripad B; AKELLA, Aparna.International journal of cardiology. 2012, Vol 157, Num 3, pp 426-427, issn 0167-5273, 2 p.Article

PRAZOSIN AS CAUSE OF URINARY INCONTINENCEKIRULUTA G; MERCER AR; WINSOR GM et al.1981; UROLOGY (RIDGEWOOD); ISSN 0090-4295; USA; DA. 1981; VOL. 18; NO 6; PP. 618-619; BIBL. 19 REF.Article

PRAZOSIN-EVALUATION OF A NEW ANTI-HYPERTENSIVE AGENT. PROCEEDINGS OF A SYMPOSIUM; GENEVA; 19741974; EXCERPTA MED., INTERNATION. CONGR. SER.; PAYS-BAS; DA. 1974; NO 331; PP. (180 P.); ABS. FR. ALLEM. ITAL. ESP. JAP.; BIBL. DISSEM.Conference Paper

SIMULTANEOUS LOSS AND REAPPEARANCE OF ALPHA ₁-ADRENERGIC RESPONSES AND (³H) PRAZOSIN BINDING SITES IN RAT LIVER AFTER IRREVERSIBLE BLOCKADE BY PHENOXYBENZAMINELYNCH CJ; DETH RC; STEER ML et al.1983; BIOCHIMICA ET BIOPHYSICA ACTA; ISSN 0006-3002; NLD; DA. 1983; VOL. 757; NO 2; PP. 156-163; BIBL. 30 REF.Article

SIDE EFFECTS DUE TO TREATMENT OF HYPERTENSION WITH PRAZOSIN. = EFFETS SECONDAIRES D'UN TRAITEMENT D'HYPERTENSION PAR LA PRAZOSINEBENDALL MJ; BALOCH KH; WILSON PR et al.1975; BRIT. MED. J.; G.B.; DA. 1975; NO 5973; PP. 727-728; BIBL. 2 REF.Article

THE DIRECT NEGATIVE CHRONOTROPIC ACTION OF PRAZOSIN ON THE CANINE SINUS NODESCHWARTZ KM; URTHALER F; JAMES TN et al.1982; JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS; ISSN 0022-3565; USA; DA. 1982; VOL. 221; NO 3; PP. 801-805; BIBL. 23 REF.Article

DIFFERENTIAL EFFECTS OF ALPHA-ADRENERGIC ANTAGONISTS ON TONIC IMMOBILITY IN DOMESTIC FOWLHENNIG CW; CARL EB; ALDRICH S et al.1981; PHARMACOL., BIOCHEM. BEHAV.; ISSN 0091-3057; USA; DA. 1981; VOL. 15; NO 5; PP. 739-742; BIBL. 24 REF.Article

EXPERIENCE WITH PRAZOSIN IN THE TREATMENT OF PATIENTS WITH SEVERE HYPERTENSIONHAYES JM; GRAHAM RM; O'CONNELL BP et al.1976; MED. J. AUSTRAL.; AUSTRAL.; DA. 1976; VOL. 1; NO 16; PP. 562-564; BIBL. 20 REF.Article

ETUDE CLINIQUE DE LA PRAZOSINE DANS LE TRAITEMENT DE L'HYPERTENSION ARTERIELLE MODEREE ET SEVEREOSTERMANN G; JOHANN P; JANODY D et al.1981; GAZ MED. FRANCE (1969); ISSN 0016-5557; FRA; DA. 1981; VOL. 88; NO 17; PP. 2493-2498; BIBL. 6 REF.Article

Alpha1-adrenergic drugs affect the development and expression of ethanol-induced behavioral sensitizationKIM, Andrezza Kyunmi; OLIVEIRA SOUZA-FORMIGONI, Maria Lucia.Behavioural brain research. 2013, Vol 256, pp 646-654, issn 0166-4328, 9 p.Article

A Pilot Trial of the Alpha-1 Adrenergic Antagonist, Prazosin, for Alcohol DependenceSIMPSON, Tracy L; SAXON, Andrew J; MEREDITH, Charles W et al.Alcoholism, clinical and experimental research. 2009, Vol 33, Num 2, pp 255-263, issn 0145-6008, 9 p.Article

Role of alpha1-and alpha2-adrenoceptors in the regulation of locomotion and spatial behavior in the active place avoidance task : A dose-response studySTUCHLIK, Ales; VALES, Karel.Neuroscience letters. 2008, Vol 433, Num 3, pp 235-240, issn 0304-3940, 6 p.Article

α1-Adrenergic receptors mediate the locomotor response to systemic administration of(±)-3,4-methylenedioxymethamphetamine (MDMA) in ratsSELKEN, Jennifer; NICHOLS, David E.Pharmacology, biochemistry and behavior. 2007, Vol 86, Num 4, pp 622-630, issn 0091-3057, 9 p.Article

Thermal analgesia induced by 30-min exposure to 1 μT burst-firing magnetic fields is strongly enhanced in a dose-dependent manner by the α₂ agonist clonidine in ratsMARTIN, L. J; PERSINGER, M. A.Neuroscience letters. 2004, Vol 366, Num 2, pp 226-229, issn 0304-3940, 4 p.Article

Effect of clonidine on colonic motility in ratsUMEZAWA, Teruyasu; SHIYU GUO; YONGYI JIAO et al.Autonomic neuroscience : basic & clinical. 2003, Vol 107, Num 1, pp 32-36, issn 1566-0702, 5 p.Article

Pre-and postsynaptic mechanisms in the clonidine-and oxymetazoline-induced inhibition of gastric motility in the ratZADON, Zoltan S; SHUJAA, Nashwan; FÜLÖP, Katalin et al.Neurochemistry international. 2007, Vol 51, Num 5, pp 297-305, issn 0197-0186, 9 p.Conference Paper

EFFECTS OF PRAZOSIN ON HEMODYNAMICS AND SYMPATHO-ADRENAL ACTIVITY IN HYPERTENSIVE PATIENTSEKLUND B; HJEMDAHL P; SEIDEMAN P et al.1983; JOURNAL OF CARDIOVASCULAR PHARMACOLOGY; ISSN 0160-2446; USA; DA. 1983; VOL. 5; NO 3; PP. 384-391; BIBL. 36 REF.Article

NOUVEAUTES THERAPEUTIQUESLESIEUR D; LESIEUR DEMARQUILLY I.1979; BULL. SOC. PHARM. LILLE; FRA; DA. 1979; VOL. 35; NO 4; PP. 195-215Article

A study on the supramolecular structure of inclusion complex of β-cyclodextrin with prazosin hydrochlorideLONGXIAO LIU; SUYAN ZHU.Carbohydrate polymers. 2007, Vol 68, Num 3, pp 472-476, issn 0144-8617, 5 p.Article

α₁-Adrenoreceptor in human hippocampus : Binding and receptor subtype mRNA expressionSZOT, Patricia; WHITE, Sylvia S; GREENUP, J. Lynne et al.Molecular brain research. 2005, Vol 139, Num 2, pp 367-371, issn 0169-328X, 5 p.Article

HYPERTENSION. PATHOPHYSIOLOGICAL ASPECTS HAEMODYNAMICS TREATMENT WITH PRAZOSIN HYDROCHLORIDE. SYMPOSIUM. PROCEEDINGS; ROTTERDAM; 1976.1977; EXCERPTA MED., INTERNATION. CONGR. SER.; PAYS-BAS; DA. 1977; NO 431; PP. 1-60; BIBL. DISSEM.Conference Paper

STUDIES WITH PRAZOSIN. A NEW EFFECTIVE HYPOTENSIVE AGENT. I. OPEN CLINICAL STUDY OF PRAZOSIN IN COMBINATION WITH OTHER ANTIHYPERTENSIVE AGENTSHUA ASP; MACDONALD IM; MYERS JB et al.1976; MED. J. AUSTRAL.; AUSTRAL.; DA. 1976; VOL. 1; NO 16; PP. 559-561; BIBL. 23 REF.Article

CLINICAL EVALUATION OF PRAZOSIN AS THE SOLE AGENT FOR THE TREATMENT OF HYPERTENSION: A DOUBLE BLIND CROSS-OVER STUDY WITH METHYLDOPA.BLOOM DS; ROSENDORFF C; KRAMER R et al.1975; CURR. THERAPEUT. RES.; U.S.A.; DA. 1975; VOL. 18; NO 1 PART. 2; PP. 144-150; BIBL. 14 REF.Article

Investigation of postjunctional α₁- and α₂-adrenoceptor subtypes in vas deferens from wild-type and α_2A/D-adrenoceptor knockout miceCLEARY, Linda; VANDEPUTTE, Catherine; DOCHERTY, James R et al.British journal of pharmacology. 2003, Vol 138, Num 6, pp 1069-1076, issn 0007-1188, 8 p.Article

PRAZOSIN: A NEW ANTIHYPERTENSIVE AGENT1975; DRUG THERAPEUT. BULL.; G.B.; DA. 1975; VOL. 13; NO 14; PP. 55-56; BIBL. 11REF.Article